Oncology ontology prototype
Read left to right: each synthetic patient has a diagnosis, which links to the labs that monitor it and the drugs that treat it. The links are hand-curated for this demonstration and are not clinical guidance.
Patient (synthetic)
SYN-001
58 F
SYN-002
67 M
SYN-003
61 M
SYN-004
72 F
SYN-005
49 M
Diagnosis (ICD-10-CM)
Breast cancer, female
C50.919
Lung cancer
C34.90
Colon cancer
C18.9
Prostate cancer
C61
Malignant brain tumor
C71.9
Chronic myeloid leukemia
C92.10
Lab (LOINC)
ER status
40556-3
PR status
40557-1
PSA, serum
2857-1
White blood cell count
6690-2
Hemoglobin
718-7
Drug (RxNorm)
Selective estrogen receptor modulator
tamoxifen
Nolvadex
Aromatase inhibitor
anastrozole
Arimidex
letrozole
Femara
CYP17 inhibitor
abiraterone
Zytiga
Tyrosine kinase inhibitor
imatinib
Gleevec
lapatinib
Tykerb
erlotinib
Tarceva
Antimetabolite
capecitabine
Xeloda
methotrexate
Trexall
Alkylating agent
temozolomide
Temodar
Synthetic patient cohort
Five made-up patients for demonstration only. They are not real people and contain no real patient data.
| Patient | Diagnosis (ICD-10-CM) | Lab results (LOINC) | Drug |
|---|---|---|---|
SYN-001 58, female | Breast cancer, female C50.919 |
|
|
SYN-002 67, male | Prostate cancer C61 |
|
|
SYN-003 61, male | Lung cancer C34.90 |
|
|
SYN-004 72, female | Colon cancer C18.9 |
|
|
SYN-005 49, male | Chronic myeloid leukemia C92.10 |
|
|